CERVICAL CANCERS
Clinical trials for CERVICAL CANCERS explained in plain language.
Never miss a new study
Get alerted when new CERVICAL CANCERS trials appear
Sign up with your email to follow new studies for CERVICAL CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could 3 radiation doses beat 4 for cervical cancer?
Disease control Recruiting nowThis study compares a shorter course of brachytherapy (3 sessions) to the standard 4-session regimen for locally advanced cervical cancer. About 41 participants will receive either 3 or 4 high-dose radiation treatments based on what is feasible for them. The goal is to see if the…
Matched conditions: CERVICAL CANCERS
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New hope for advanced cancers: experimental drug XNW28012 enters human trials
Disease control Recruiting nowThis study tests a new drug called XNW28012 in people with advanced solid tumors (pancreatic, ovarian, cervical, or colorectal cancers) that have stopped responding to standard treatments. The trial has two parts: first, finding a safe dose, then expanding to see if the drug shri…
Matched conditions: CERVICAL CANCERS
Phase: PHASE1, PHASE2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Cancer-Killing virus trial launches for patients out of options
Disease control Recruiting nowThis Phase 1 trial tests IDOV-Immune, a genetically engineered virus designed to infect and destroy cancer cells while boosting the immune system. It is for adults with advanced solid tumors (like colorectal, pancreatic, or lung cancer) that have not responded to standard treatme…
Matched conditions: CERVICAL CANCERS
Phase: PHASE1 • Sponsor: ViroMissile, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New drug combo aims to stop cervical cancer recurrence in high-risk patients
Disease control Recruiting nowThis study tests whether adding the drug serplulimab to standard chemoradiotherapy after surgery can help prevent cervical cancer from returning in patients with multiple risk factors. About 134 women aged 18-65 with PD-L1 positive cervical cancer will be randomly assigned to rec…
Matched conditions: CERVICAL CANCERS
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can a special shake help cervical cancer patients tolerate chemo better?
Disease control Recruiting nowThis study tests whether a special nutritional drink (immunonutrition) can help malnourished cervical cancer patients better tolerate chemotherapy and improve their quality of life. Fifty patients receiving standard chemoradiation will be randomly assigned to get either the speci…
Matched conditions: CERVICAL CANCERS
Phase: NA • Sponsor: SHUANG ZHENG JIA, PhD • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
AI-Powered camera could spot cervical cancer without a lab
Diagnosis Recruiting nowThis study is testing a new, low-cost screening tool for cervical cancer that uses artificial intelligence to analyze digital images of the cervix. It does not require a lab and can be used at the point of care. The goal is to see if this AI tool can accurately detect precancerou…
Matched conditions: CERVICAL CANCERS
Phase: NA • Sponsor: DL Analytics • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
At-Home HPV tests could boost cervical cancer screening in border communities
Prevention Recruiting nowThis study tests whether at-home HPV self-sampling (using urine or a vaginal swab) can help more people get screened for cervical cancer compared to the traditional in-clinic Pap smear. About 735 Latinx individuals aged 30-65 who haven't had a Pap test in at least three years wil…
Matched conditions: CERVICAL CANCERS
Phase: NA • Sponsor: University of Texas at Austin • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
Can a simple pill make cervical cancer screening more effective?
Symptom relief Recruiting nowThis study tests whether the drug misoprostol, given before a cervical exam, can help doctors see the cervix more clearly. 420 women with a hard-to-examine cervix (called Type 3 transformation zone) will receive either misoprostol or a placebo. The goal is to see if the drug make…
Matched conditions: CERVICAL CANCERS
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC